Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Community Health Systems, Inc. (CYH) SEC Filings & Earnings Calls

EquiReason read 19 Community Health Systems, Inc. SEC filings in the last 12 months. Latest: 10-Q on 2026-07-23 — Q2 2026 net income fell 75% YoY to $70M, driven by divestitures, higher charity care, and salary inflation; same-store revenue grew 2.4%..

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CYHCommunity Health Systems, Inc.Follow CYH — free
Medical Care Facilities · Healthcare
—
Price chart with a free account
Market cap
411.7M
P/E TTM
1.6
Dividend yield
—
52-week
—
Next earnings
28 Oct, in 4 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

23 Jul 202610-QQ2 2026 net income fell 75% YoY to $70M, driven by divestitures, higher charity care, and salary inflation; same-store revenue grew 2.4%.earningsopen

Figures in the filing · each found in the filing text

Net operating revenues · Q2-2026$2.83B-10% y/y
Net income attributable to Community Health Systems, Inc. stockholders · Q2-2026$70M-75% y/y
Operating cash flow · H1-2026$-209M
ABL availability · 2026-06-30$751M
Same-store inpatient admissions change · Q2-20261.9%
Same-store adjusted admissions change · Q2-20262.9%
Capital expenditures · H1-2026$152M-14% y/y
Net proceeds from divestitures · H1-2026$1.20B

Guidance

2026 capex guided $350M-$400M

Management reaffirmed 2026 capex guidance of $350M-$400M; no formal revenue or earnings guidance provided.

Risks flagged

Medicaid/ACA coverage loss

“The 2025 Reconciliation Law includes healthcare policy changes that are expected to decrease access to health insurance and result in significant cuts to federal healthcare spending.” · word for word

Charity care cost increase

“The amount of foregone revenue related to providing charity care services as a percentage of net operating revenues was approximately 18.3% and 10.7% for the three months ended June 30, 2026 and 2025, respectively.” · word for word

Regulatory uncertainty from Supreme Court decisions

“These U.S. Supreme Court decisions increase judicial scrutiny of agency authority, shift greater responsibility for statutory interpretation to courts and expand the timeline in which a plaintiff can sue regulators.” · word for word
Read the original on SEC EDGAR ↗
22 Jul 20268-K · 2.02, 7.01Net operating revenues $2.83B (-10% y/y); Net income attributable to stockholders $70M (-75% y/y); Diluted EPS (GAAP) $0.51 (-76% y/y); Guidance: Updated annual earnings guidance included in press release (specific numbers not in excerpt)earningsopen

Figures in the filing · each found in the filing text

Net operating revenues · Q2-2026$2.83B-10% y/y
Net income attributable to stockholders · Q2-2026$70M-75% y/y
Diluted EPS (GAAP) · Q2-2026$0.51-76% y/y
Adjusted diluted EPS (non-GAAP) · Q2-2026$-0.19
Adjusted EBITDA · Q2-2026$330M-13% y/y
Net cash provided by operating activities · Q2-2026$87M0% y/y
Same-store admissions change · Q2-20261.9%
Same-store adjusted admissions change · Q2-20262.9%

Guidance

Updated annual earnings guidance included in press release (specific numbers not in excerpt)

Updated annual guidance reflects lower earnings expectations due to divestitures, payor mix, and cost pressures.

Risks flagged

Payor mix deterioration pressuring margins; higher proportion of government/less profitable payors.

“Unfavorable change in payor mix cited as key driver of Adjusted EBITDA decline.”

Medical specialist fee inflation adding cost pressure.

“Higher medical specialist fees cited as key driver of Adjusted EBITDA decline.”

Divestiture strategy reduces scale and may impact long-term revenue growth.

“Total revenue -9.8% primarily due to divestitures; same-store growth +2.4% insufficient to offset.”
Read the original on SEC EDGAR ↗
1 Jun 20268-K · 2.01, 8.01Completed an acquisition or disposition of significant assets; disclosed a material event under other events (litigation, recall, contract loss, or major announcement)acquisitionopen

Risks flagged

Loss of revenue and earnings contribution from divested hospitals may pressure overall financial performance.

“Pro forma financial statements required due to significant disposition.”
Read the original on SEC EDGAR ↗
6 May 20268-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportopen

Risks flagged

High coupon debt (10.875% 2032 Notes) suggests elevated interest burden; tender may reduce leverage.

“Tender offer includes 10.875% Senior Secured Notes due 2032.”
Read the original on SEC EDGAR ↗
23 Apr 20268-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportopen

Risks flagged

High coupon debt (10.875% 2032 Notes) suggests elevated interest burden; tender may reduce leverage.

“Tender offer includes 10.875% Senior Secured Notes due 2032.”
Read the original on SEC EDGAR ↗
22 Apr 202610-QNet Operating Revenues $2.96B (-6% y/y); Net Loss Attributable to Stockholders $-58M (+346% y/y); Same-Store Net Operating Revenues Growth 3.1; Guidance: 2026 capital expenditures expected $350M to $400Mopen

Figures in the filing · each found in the filing text

Net Operating Revenues · Q1-2026$2.96B-6% y/y
Net Loss Attributable to Stockholders · Q1-2026$-58M+346% y/y
Same-Store Net Operating Revenues Growth · Q1-20263.1%
Same-Store Inpatient Admissions Growth · Q1-2026-1.3%
Same-Store Adjusted Admissions Growth · Q1-2026-0.5%
Capital Expenditures · Q1-2026$76M-11% y/y
ABL Availability · Q1-2026$824M
Total Debt · Q1-2026$10.20B

Guidance

2026 capital expenditures expected $350M to $400M

Management reaffirmed 2026 capex guidance of $350M-$400M, but did not provide explicit revenue or margin guidance.

Risks flagged

Medicaid Funding Reduction

“We expect the law to adversely impact our revenue and financial results as well as increase the amount of our self-pay patients, including as a result of this legislation’s limitations on Medicaid eligibility and reductions in federal Medicaid funding as noted above.” · word for word

Negative Operating Cash Flow

“Net cash provided by operating activities changed by $417 million, from approximately $120 million of cash provided by operating activities for the three months ended March 31, 2025, to cash used in operating activities of approximately $297 million for the three months ended March 31, 2026.” · word for word

High Leverage

“As of March 31, 2026, approximately $29 million of our outstanding debt of approximately $10.2 billion is due within the next 12 months.” · word for word
Read the original on SEC EDGAR ↗
21 Apr 20268-K · 2.02, 7.01Net operating revenues $2.96B (-6% y/y); Net loss attributable to Community Health Systems, Inc. stockholders $-58M; Loss per share (diluted) $-0.43earningsopen

Figures in the filing · each found in the filing text

Net operating revenues · Q1-2026$2.96B-6% y/y
Net loss attributable to Community Health Systems, Inc. stockholders · Q1-2026$-58M
Loss per share (diluted) · Q1-2026$-0.43
Adjusted EBITDA · Q1-2026$309M-18% y/y
Net cash used in operating activities · Q1-2026$-297M
Same-store admissions change · Q1-2026-1.3%
Same-store adjusted admissions change · Q1-2026-0.5%

Risks flagged

Divestiture of multiple hospitals reduces revenue base and creates transition risk.

“During 2026, through the date of this press release, the Company divested three hospitals as well as its 80% ownership interest in one other hospital, all effective on February 1, 2026, and divested one other hospital, effective April 1, 2026.” · word for word

Unfavorable payor mix and lower same-store volumes driving margin compression.

“lower same-store volumes, an unfavorable change in payor mix” · word for word

Negative operating cash flow of $297M raises liquidity concerns.

“Net cash used in operating activities was $297 million” · word for word
Read the original on SEC EDGAR ↗
2 Apr 2026DEF 14AAnnual proxy statement disclosing executive compensation, governance, and 2025 financial results.open

Figures in the filing · each found in the filing text

Net Operating Revenue · FY2025$12.48B
Adjusted EBITDA · FY2025$1.53B-1% y/y
Net Income (Loss) Attributable to Stockholders · FY2025$509M
Adjusted EBITDA Margin Improvement · FY20250.0%
Cumulative Same-Store Net Revenue Growth (3-year) · 2023-202515.0%
Adjusted Diluted EPS · FY2025$1.19

Risks flagged

High Leverage

“The Company completed multiple debt offerings and tender offers to manage its capital structure, indicating high leverage.”

Operating Environment Challenges

“Despite ongoing challenges in the operating environment in 2025” · word for word

CEO Transition Risk

“Mr. Hingtgen retired as CEO on September 30, 2025. Mr. Hammons was appointed CEO on December 10, 2025.”
Read the original on SEC EDGAR ↗
1 Apr 20268-K · 2.01, 8.01Purchase price $459Macquisitionopen

Figures in the filing · each found in the filing text

purchase price · point_in_time$459M

Risks flagged

Loss of revenue and earnings from divested hospital; proceeds may be used for debt reduction, but future earnings base is reduced.

“Sale of Crestwood Medical Center and associated outpatient centers; pro forma financials filed.”
Read the original on SEC EDGAR ↗
5 Mar 20268-K · 1.01, 8.01Community Health Systems (CHS) entered an Asset Purchase Agreement to sell four Arkansas hospitals to Freeman Health System for $112M, expected to close Q2 2026. CHS is the seller (target of divestiture).being acquiredopen

Figures in the filing · each found in the filing text

Purchase price for hospital assets · Q2-2026$112M

Risks flagged

Transaction subject to closing conditions and may not close; potential disruption from divestiture.

“closing of the Transaction is subject to the satisfaction or waiver of certain closing conditions” · word for word
Read the original on SEC EDGAR ↗
19 Feb 202610-KNet operating revenues $12.48B (-1% y/y); Net income (loss) attributable to Community Health Systems, Inc. stockholders $509M (+199% y/y); Adjusted EBITDA $1.53B (-1% y/y)open

Figures in the filing · each found in the filing text

Net operating revenues · FY2025$12.48B-1% y/y
Net income (loss) attributable to Community Health Systems, Inc. stockholders · FY2025$509M+199% y/y
Adjusted EBITDA · FY2025$1.53B-1% y/y
Adjusted EBITDA as a % of net operating revenues · FY202512.2%
Net cash flows provided by operating activities · FY2025$543M+13% y/y
Same-store net operating revenues · FY2025$12.23B+5% y/y
Same-store inpatient admissions · FY2025392,348+2% y/y
Same-store adjusted admissions · FY2025881,808+1% y/y
Licensed beds (at end of period) · FY202510,458-8% y/y
Admissions · FY2025399,255-5% y/y

Risks flagged

Medicaid funding cuts from 2025 Reconciliation Law

“Although we are unable to fully assess the magnitude of the future impact of the 2025 Reconciliation Law, we expect the law to adversely impact our revenue and financial results as well as increase the amount of our self-pay patients, including as a result of this legislation's limitations on Medicaid eligibility and reductions in federal Medicaid funding as” · word for word

High leverage and debt service burden

“Interest expense, net, increased by $10 million to $870 million for the year ended December 31, 2025 compared to $860 million for the same period in 2024.” · word for word

Cybersecurity and data breach risk

“In particular, on February 13, 2023, we disclosed a security incident in which a third-party vendor who provides a secure file transfer software platform utilized by our subsidiaries experienced a security breach whereby PHI and personal information of certain patients of our healthcare facilities were exposed to an unauthorized third party.” · word for word
Read the original on SEC EDGAR ↗
18 Feb 20268-K · 2.02, 7.01Net Operating Revenues $3.11B (-5% y/y); Net Income $110M; Adjusted EBITDA $395M (-8% y/y)earningsopen

Figures in the filing · each found in the filing text

Net Operating Revenues · Q4-2025$3.11B-5% y/y
Net Income · Q4-2025$110M
Adjusted EBITDA · Q4-2025$395M-8% y/y
Net Cash Provided by Operating Activities · Q4-2025$266M+23% y/y
Same-Store Admissions Change · Q4-2025-0.3%
Same-Store Adjusted Admissions Change · Q4-2025-0.3%
Diluted EPS · Q4-2025$0.81

Risks flagged

Decline in reported revenue due to divestitures may indicate portfolio restructuring risk.

“Net operating revenues decreased 4.9% due to divestitures.”

Same-store admissions decline of 0.3% suggests potential volume pressure.

“Same-store admissions decreased 0.3%.”
Read the original on SEC EDGAR ↗
11 Feb 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open

Risks flagged

Organizational restructuring and executive departures may indicate management instability or strategic shift.

“Former CEO retired Sep 2025; former President retired Dec 2024; one executive ceased to be an officer due to organizational changes effective May 2025.”
Read the original on SEC EDGAR ↗
2 Feb 20268-K · 2.01, 8.01Sale proceeds $623M; Additional distribution $23Macquisitionopen

Figures in the filing · each found in the filing text

Sale proceeds · 2026-02-01$623M
Additional distribution · 2026-02-01$23M

Risks flagged

Reduction in hospital portfolio scale

“Sale of 80% interest in Tennova Healthcare - Clarksville”
Read the original on SEC EDGAR ↗
20 Jan 20268-K · 1.01, 8.01Community Health Systems agreed to sell Crestwood Medical Center assets to Huntsville Hospital Health System for $450M; expected close Q2 2026.being acquiredopen

Figures in the filing · each found in the filing text

Purchase price · Crestwood Medical Center · Q2-2026$450M

Risks flagged

Transaction subject to closing conditions; risk of non-completion or delay.

“closing of the Transaction is subject to the satisfaction or waiver of certain closing conditions” · word for word
Read the original on SEC EDGAR ↗
10 Dec 20258-K · 5.02Reported the departure of a director or principal officer (CEO/CFO change); filed financial statements and exhibits with this reportopen

Risks flagged

Leadership transition risk, but no specifics on departure reason or successor.

“Press release announcing departure of a director or principal officer.”
Read the original on SEC EDGAR ↗
2 Dec 20258-K · 2.01, 8.01Purchase price $194Macquisitionopen

Figures in the filing · each found in the filing text

purchase price · ambulatory outreach business · Q4-2025$194M

Risks flagged

Sale reduces revenue base from ambulatory outreach services, though likely non-core.

“Purchaser acquired from certain subsidiaries of CHS the select assets and assumed certain leases of CHS’s ambulatory outreach business across 13 states” · word for word
Read the original on SEC EDGAR ↗
31 Oct 20258-K · 1.01, 8.01Purchase Price $600Mopen

Figures in the filing · each found in the filing text

Purchase Price · 2026$600M

Risks flagged

Transaction subject to regulatory approvals and closing conditions; may not close on expected timeline.

“Consummation of the Transaction is expected to occur in early 2026, subject to regulatory approvals and closing conditions.” · word for word
Read the original on SEC EDGAR ↗
24 Oct 202510-QQ3 2025 net income of $171M vs net loss of $(355)M in Q3 2024, driven by lower impairment charges, a tax benefit, and improved operating margins.earningsopen

Figures in the filing · each found in the filing text

Net operating revenues · Q3-2025$3.09B-0% y/y
Net income (loss) attributable to Community Health Systems, Inc. stockholders · Q3-2025$130M+133% y/y
Operating cash flow · 9M-2025$277M+5% y/y
ABL availability · 2025-09-30$806M
Asset proceeds from sale · 9M-2025$1.00B
Capital expenditures · 9M-2025$241M-4% y/y
Same-store net operating revenues growth · Q3-20256.0%
Same-store inpatient admissions growth · Q3-20251.3%
Same-store adjusted admissions growth · Q3-20250.3%

Guidance

Capital expenditures guided to $350M-$400M for 2025

Capital expenditure guidance of $350M-$400M for 2025; no revenue or earnings guidance provided, but management tone is positive given improved operating results.

Risks flagged

Medicaid funding cuts from 2025 Reconciliation Law

“Although we are unable to fully assess the magnitude of the future impact of the 2025 Reconciliation Law, we expect the 2025 Reconciliation Law as described above to adversely impact our revenue and financial results as well as increase the amount of our self-pay patients, including as a result of this legislation's limitations on Medicaid eligibility and re” · word for word

Medicare payment reductions from sequestration and outpatient PPS changes

“a Medicare spending reduction of up to 4% is required to take effect in early 2026, absent congressional action.” · word for word

Regulatory uncertainty from Supreme Court decisions and executive actions

“Regulatory uncertainty has increased as a result of recent decisions issued by the U.S. Supreme Court that affect review of federal agency actions, including Loper Bright Enterprises v. Raimondo, and the outcome of the 2024 federal elections.” · word for word

High leverage and refinancing risk

“As of September 30, 2025, approximately $16 million of our outstanding debt of approximately $10.6 billion is due within the next 12 months.” · word for word
Read the original on SEC EDGAR ↗

Community Health Systems, Inc. — questions

What did Community Health Systems, Inc. file recently?
19 SEC filings in the last 12 months. Latest: 10-Q on 2026-07-23 — Q2 2026 net income fell 75% YoY to $70M, driven by divestitures, higher charity care, and salary inflation; same-store revenue grew 2.4%.

Every figure on this page comes from Community Health Systems, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.